Skip to main content
Premium Trial:

Request an Annual Quote

George Adam, Christopher Hibberd

Premium
Applera, the parent company of Applied Biosystems and Celera, last week named George Adam to its board, expanding it to 11 members. The move anticipates the retirement of some current board members during the next several years and a need for additional directors if Applied Biosystems and Celera are split into independent companies, each with its own board, Applera said in a statement.
 
In early August, Applera said that it had retained Morgan Stanley to explore alternatives to its current corporate tracking stock structure, including possibly spinning out the two companies [See PM 08/09/07].
 

 

Oxford Genome Sciences this week said Christopher Hibberd has joined its board. Hibberd is currently CEO of Astute Medical. Prior to that, he was senior vice president of corporate development at Biosite where he was responsible for identifying and pursuing strategic business opportunities.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.